Abstract:Gossypol, a sesquiterpenoid found in cotton seeds, exerts anticancer effects on several tumor entities due to inhibition of DNA synthesis and other mechanisms. In clinical oncology, histone deacetylase inhibitors (HDACi) are applied as anticancer compounds. In this study, we examined whether gossypol harbors HDAC inhibiting activity. In vitro analyses showed that gossypol inhibited class I, II, and IV HDAC, displaying the capability to laterally interact with the respective catalytic center and is, therefore, classified as a pan-HDAC inhibitor. Next, we studied the effects of gossypol on human-derived hepatoma (HepG2) and colon carcinoma (HCT-116) cell lines and found that gossypol induced hyperacetylation of histone protein H3 and/or tubulin within 6 h. Furthermore, incubation with different concentrations of gossypol (5–50 μM) over a time period of 96 h led to a prominent reduction in cellular viability and proliferation of hepatoma (HepG2, Hep3B) and colon carcinoma (HCT-116, HT-29) cells. In-depth analysis of underlying mechanisms showed that gossypol induced apoptosis via caspase activation. For pre-clinical evaluation, toxicity analyses showed toxic effects of gossypol in vitro toward non-malignant primary hepatocytes (PHH), the colon-derived fibroblast cell line CCD-18Co, and the intestinal epithelial cell line CCD 841 CoN at concentrations of ≥5 μM, and embryotoxicity in chicken embryos at ≥2.5 μM. In conclusion, the pronounced inhibitory capacity of gossypol on cancer cells was characterized, and pan-HDACi activity was detected in silico, in vitro, by inhibiting individual HDAC isoenzymes, and on protein level by determining histone acetylation. However, for clinical application, further chemical optimization is required to decrease cellular toxicity.

The (+)- and (−)-gossypols potently inhibit human and rat 11β-hydroxysteroid dehydrogenase type 2

The (+)- and (-)-gossypols Potently Inhibit Both 3 Beta-Hydroxysteroid Dehydrogenase and 17 Beta-Hydroxysteroid Dehydrogenase 3 in Human and Rat Testes

The Effects of (+)-Gossypol on 11 Beta-Hsd and the Concentration of Corticosterone and Dehydrocorticosterone in Mice Serum and Tissues

Inhibition of T-type Ca2+ currents in mouse spermatogenic cells by gossypol, an antifertility compound

Zero-Order Release of Gossypol Improves Its Antifertility Effect and Reduces Its Side Effects Simultaneously

A New Antifertility Mechanism of Gossypol: Inhibition on Phospholipase

Structure, Properties of Gossypol and Its Derivatives—from Physiological Activities to Drug Discovery and Drug Design

Inhibitory Effects of Gossypol on the Activation of Human T-lymphocytes Stimulated with Polyclonal Activators

Gossypol inhibits follicle-stimulating hormone- and epidermal growth factor-stimulated expansion of oocyte-cumulus complexes from porcine preovulatory follicles

Benzophenone-1 and -2 UV-filters potently inhibit human, rat, and mouse gonadal 3β-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico docking analysis

The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.

Changes of serum concentrations of testosterone, LH and FSH in men taking gossypol]

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

The Immunosuppressive Effect of Gossypol in Mice is Mediated by Inhibition of Lymphocyte Proliferation and by Induction of Cell Apoptosis

Gossypol repressed the gap junctional intercellular communication between Sertoli cells by decreasing the expression of Connexin43.

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma

Direct inhibition of bisphenols on human and rat 11β-hydroxysteroid dehydrogenase 2: Structure-activity relationship and docking analysis

Comparison of the efficacy of gossypol acetate enantiomers in rats with uterine leiomyoma

Metabolomic Profiling and Network Toxicology: Mechanistic Insights into Effect of Gossypol Acetate Isomers in Uterine Fibroids and Liver Injury